227 related articles for article (PubMed ID: 24785373)
21. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
Costa PM; Cardoso AL; Nóbrega C; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
Hum Mol Genet; 2013 Mar; 22(5):904-18. PubMed ID: 23201752
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation.
Bassi C; Mello SS; Cardoso RS; Godoy PD; Fachin AL; Junta CM; Sandrin-Garcia P; Carlotti CG; Falcão RP; Donadi EA; Passos GA; Sakamoto-Hojo ET
Hum Exp Toxicol; 2008 Dec; 27(12):919-29. PubMed ID: 19273547
[TBL] [Abstract][Full Text] [Related]
23. miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
Zhang W; Shen C; Li C; Yang G; Liu H; Chen X; Zhu D; Zou H; Zhen Y; Zhang D; Zhao S
Mol Carcinog; 2016 May; 55(5):575-85. PubMed ID: 25764520
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
Xu X; Zhang F; Chen X; Ying Q
Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
[TBL] [Abstract][Full Text] [Related]
25. miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
Peng G; Yuan X; Yuan J; Liu Q; Dai M; Shen C; Ma J; Liao Y; Jiang W
Mol Cell Biochem; 2015 Nov; 409(1-2):103-11. PubMed ID: 26209061
[TBL] [Abstract][Full Text] [Related]
26. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Xu G; Li JY
Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
[TBL] [Abstract][Full Text] [Related]
28. miR-340 suppresses glioblastoma multiforme.
Huang D; Qiu S; Ge R; He L; Li M; Li Y; Peng Y
Oncotarget; 2015 Apr; 6(11):9257-70. PubMed ID: 25831237
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
30. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors.
D'Urso PI; D'Urso OF; Storelli C; Mallardo M; Gianfreda CD; Montinaro A; Cimmino A; Pietro C; Marsigliante S
Int J Oncol; 2012 Jul; 41(1):228-34. PubMed ID: 22470130
[TBL] [Abstract][Full Text] [Related]
31. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells.
Zhang X; Zhang X; Hu S; Zheng M; Zhang J; Zhao J; Zhang X; Yan B; Jia L; Zhao J; Wu K; Yang A; Zhang R
Nucleic Acids Res; 2017 Jun; 45(10):5930-5944. PubMed ID: 28459998
[TBL] [Abstract][Full Text] [Related]
32. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
33. Chemo-resistance of A172 glioblastoma cells is controlled by miR-1271-regulated Bcl-2.
Yang L; Wang Y; Li YJ; Zeng CC
Biomed Pharmacother; 2018 Dec; 108():734-740. PubMed ID: 30248541
[TBL] [Abstract][Full Text] [Related]
34. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Chan JA; Krichevsky AM; Kosik KS
Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
[TBL] [Abstract][Full Text] [Related]
36. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53 and miRNA expression after irradiation of glioblastoma cell lines.
Sasaki A; Udaka Y; Tsunoda Y; Yamamoto G; Tsuji M; Oyamada H; Oguchi K; Mizutani T
Anticancer Res; 2012 Nov; 32(11):4709-13. PubMed ID: 23155233
[TBL] [Abstract][Full Text] [Related]
38. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
[TBL] [Abstract][Full Text] [Related]
39. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
40. MiR-522 contributes to cell proliferation of human glioblastoma cells by suppressing PHLPP1 expression.
Zhang S; Zhang H; Zhu J; Zhang X; Liu Y
Biomed Pharmacother; 2015 Mar; 70():164-9. PubMed ID: 25776496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
